Use of Antibodies against il-6 receptor (il-6r) and an immunosuppressant, preferably.Because it serves to prepare a drug used in the treatment of diseases related to il-6, preferably, rheumatoid arthritis.

摘要

A pharmaceutical composition for the treatment of interleukin-6 (IL-6) related diseases, comprising an interleukin-6 antagonist (IL-6 antagonist) and immunosuppressants. The IL-6 antagonist is preferably an antibody to an interleukin-6 receptor (IL-6R).